Description | This is a human IgG1, λ monoclonal antibody designed to target BoNT/A. It is suitable for use in ELISA, Neut, WB, and Inhib assay. The antibody exhibited a 92% inhibition of the cleavage induced by BoNT/A. Through ELISA, it was observed that the antibody specifically binds to the BoNT/A LC, and not to the BoNT/A heavy chain. Furthermore, when administered alone, the antibody demonstrated potent in vivo neutralization, and in collaboration with an antibody specific for the HC. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | C. botulinum |
Neutralization Potency | An equimolar mix of 6A and 4LCA antibodies neutralized BoNT/A with a potency of 10,000 LD50/mg antibody. |
Affinity | KD = 31 pM |
Isotype | Human IgG1, lambda |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein A affinity purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | ELISA; Neut; WB; Inhib |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | BONT-A |
Alternative Name | Botulinum Toxin Type A; BONT-A |
Research Area | Microbiology |